A practical reference on WADA: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-08 and is reviewed periodically as new material appears.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
=== Netball === 10 September - Netball New Zealand suspends the Silver Ferns' coach Dame Noeline Taurua over concerns over her management style and bullying allegations. 25 October – Following an internal investigation and protracted negotiations, Netball New Zealand reinstates Dame Taurua as the Silver Ferns' coach, effective late 2025.
=== Cyclodextrin (CD) chiral stationary phases === Cyclodextrin (CD) chiral stationary phase is produced by partial degradation of starch by the enzyme cyclodextrin glycosyltransferase, followed by enzymatic coupling of the glucose units, forming a toroidal structure. CDs are cyclic oligosaccharides consisting of six (α CDs), seven (β CDs) and eight (γ CDs) glucopyranose units. The chiral recognition mechanism is based on a sort of inclusion complexation. Complexation involves the interaction of the hydrophobic portion of an analyte enantiomer with the non-polar interior of the cavity, while the polar functional groups can form a hydrogen bond with the polar hydroxyl chiral cavity space. The most important factor that determines whether the analyte molecule will fit into the cyclodextrin cavity is its size. The α-CD consists of 30 stereo-selective centers, β-CD consists of 35 stereo-selective centers and γ-CD consists of 40 stereo-selective centers. When the hydrophobic portion of the analyte is larger or smaller than the toroid's cavity size, inclusion will not occur.
Radiation protection measures may also be necessary against scattered radiation, which occurs during tumor irradiation of the head and neck on metal parts of the dentition (dental fillings, bridges, etc.). Since the 1990s, soft tissue retractors known as radiation protection splints have been used to prevent or reduce mucositis, an inflammation of the mucous membranes. It is the most significant adverse acute side effect of radiation. The radiation protection splint is a spacer that keeps the mucosa away from the teeth and reduces the amount of scattered radiation that hits the mucosa according to the square law of distance. Mucositis, which is extremely painful, is one of the most significant detriments to a patient's quality of life and often limits radiation therapy, thereby reducing the chances of tumor cure. The splint reduces oral mucosal reactions that typically occur in the second and third third of a radiation series and are irreversible.
== Career == In 2004, Friedler joined the Institute of Chemistry at the Hebrew University of Jerusalem as a senior lecturer. He became an associate professor with tenure in 2009 and was appointed full professor in 2015. From 2005 to 2009, he headed the university's undergraduate chemistry–biology programme. He was head of the School of Chemistry. Friedler served as vice rector of the Hebrew University from 2016 to 2020. During the same period, he chaired the university's central student admissions committee. He was dean of its Faculty of Science from 2020 to 2024. He chaired the Hebrew University for the Youth from 2019 to 2024. In October 2024, Friedler became director and chief executive officer of SHARE, the Singapore–Hebrew University Alliance for Research and Enterprise.
Sources: en.wikipedia.org
== Diagnosis == The diagnosis of GPS is often difficult, as numerous other diseases can cause the various manifestations of the condition, and the condition itself is rare. The most accurate means of achieving the diagnosis is testing the affected tissues by means of a biopsy, especially the kidney, as it is the best-studied organ for obtaining a sample for the presence of anti-GBM antibodies. On top of the anti-GBM antibodies implicated in the disease, about one in three of those affected also has cytoplasmic antineutrophilic antibodies in their bloodstream, which often precedes the anti-GBM antibodies by a few months or even years. The later the disease is diagnosed, the worse the outcome is for the affected person. In addition, if there is substantial suspicion of the disease, serologic testing for the ELISA assay is usually done by looking for the alpha3 NC1 domain area of collagen IV to avoid false positives.
=== Animal glutamate–cysteine ligase === Animal glutamate cysteine ligase (GCL) is a heterodimeric enzyme composed of two protein subunits that are coded by independent genes located on separate chromosomes:
== Early modern period == In the 15th century, Catanzaro was exporting its silk cloth and its technical skills to neighbouring Sicily. By the middle of the century, silk spinning had achieved scale in Catanzaro. Catanzaro's silk industry supplied almost all of Europe and was sold at large fairs to Spanish, Venetian, Genoan, Florentine, and Dutch merchants. The city was famous for its manufacture of silks, velvets, damasks and brocades. In 1519, Emperor Charles V formally recognized the growth of Catanzaro's silk industry, allowing the city to establish a consulate of silk crafts, charged with regulating and controlling the various stages of a production that flourished throughout the 16th century. In 1442, the Aragonese took control under Alfonso V of Aragon who became ruler under the Crown of Aragon. In 1501 Calabria came under the control of Ferdinand II of Aragon, whose wife Queen Isabella of Castille is famed for sponsoring the first voyage of Christopher Columbus in 1492. Calabria suffered under Aragonese rule with heavy taxes, feuding landlords, starvation, and sickness. After a brief period in the early 1700s under the Habsburgs, Calabria came under the control of the Spanish Bourbons in 1735. During the 16th century Calabrian doctor and astronomer Luigi Lilio created the Gregorian calendar. In 1466, King Louis XI decided to develop a national silk industry in Lyon and employed many Italian workers, mainly from Calabria. The fame of the master weavers of Catanzaro spread throughout France. They were invited to Lyon to teach the techniques of weaving.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.